Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salmeterol-fluticasone combination and tiotropium for bronchial anthracofibrosis
IRCT201404072695N5Phase 2Completed
- Sponsor
- Cipla
- Start
- Nov 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of salmeterol + fluticasone, tiotropium in Bronchial Anthracofibrosis (BAF), anthracosis (CWP), sponsored by Cipla. Started Nov 2014; status: completed.
02
Drugs
salmeterol + fluticasonetiotropium
03
Conditions
Bronchial Anthracofibrosis (BAF)anthracosis (CWP)
Beyond the preview
Go deeper on IRCT201404072695N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201404072695N5.